Formation Venture Engineering
Venture studioBoston · Pre-Seed · 19 people tracked
Find your way into Formation Venture Engineering
2,630 people in our graph share verified history with the Formation Venture Engineering team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Formation Venture Engineering argues that traditional investing misaligns the incentives of scientists, founders, and LPs. It partners with leading institutions and companies to source proven, high-impact IP with large untapped commercial potential, and cross-pollinates IP across disciplines to unlock new commercial use cases. The firm actively co-founds companies around this IP alongside scientific cofounders, running a rigorous 'Venture Engineering' process to systematically de-risk both the technology and the commercial opportunity. Operating as a venture holdco, it is designed to reach fast, high-quality exits that produce equitable outcomes for all stakeholders.
Source: firm website, verified Aug 16, 2026.
Team · 19 people
from the firm's website & public directories
Founder mafia
2 people who came through Formation Venture Engineering went on to found or lead other companies.
What they invest in
from 8 of 12 portfolio companiesBiotech ×7Healthtech ×4Medical Devices ×4AI & Machine Learning ×2Deep Tech ×2Digital Health ×1Hardware ×1
HQs:United States×6
Investments · 12 tracked
founders shown can be your intro pathBy year:2022 · 22021 · 12020 · 14 dated
Adeptrix develops the exoBAMS platform, using antibody-based immunoaffinity capture of extracellular vesicles combined with MALDI mass spectrometry to profile proteins, lipids, metabolites and other molecules from a single blood sample.
AI & Machine LearningBiotechMedical Devices
Akston Biosciences develops protein-based therapies for pets to support veterinary care and improve treatment accessibility.
BiotechHealthtechBeverly, US
Todd C. Zion(Executive Officer, Director)inJames Herriman(Executive Officer)Robyn Davis(Director)Lovick E. Cannon(Director)Thomas M. Lancaster(Executive Officer, Director)
Co-investorsBoston Harbor Angels
Reimagining hospital beds as diagnostic and therapeutic devices; sensor-cell technology monitors airflow, pressure, and skin health to prevent and heal bedsores.
LeviSense Medical is a Massachusetts-based medical device company developing next-generation technology for therapeutic beds used in wound care.
HardwareHealthtechMedical DevicesBeverly, US
Dave Bertoni(COO & Co-Founder)inShri Parikh(CEO & Director)inMichael McGarrity(Director)Peter Rock(Chief Financial Officer)inDonald Dye(Director)
BoardRahul Bhansali(Director)in
Co-investorsICV Venture Engineering
NeuroDex develops blood-based biomarkers and diagnostic assays for neurological diseases, including rare genetic disorders, Parkinson's disease, Alzheimer's disease, and ALS.
BiotechDigital HealthMedical DevicesArlington, US
Erez Eitan(Executive Officer, Director)inRaphael Nir(Director)Oded Biran(Executive Officer, Director)
Co-investorsICVICV Venture Engineering
NonExomics is a drug discovery company that uses a machine learning platform integrating genomics, transcriptomics, and proteomics to identify novel "noncanonical" proteins encoded across the entire human genome, including the previously unstudied 98% "dark genome." It has cataloged hundreds of thousands of such proteins and thousands of novel druggable targets associated with over 1,300 human diseases for therapeutic development.
AI & Machine LearningBiotechDeep TechHealthtechActon, US
Ruchi Chauhan(Director)
Co-investorsIllumina Accelerator
Builds scalable platforms for oligo synthesis and conjugation to support diagnostics and therapeutics.
BiotechEncinitas, US
Jimmy Hollis Williams(Executive Officer, Director)
Developing a precision immunotherapy approach to Alzheimer's, chronic pain, and neurodegenerative diseases; first graduate of FVE Foundry.
Twilight develops injectable precision immunotherapies to train the body's immune system to treat chronic diseases at scale.
BiotechDeep TechHealthtechMedical Devices
Ajay Verma(CEO, Co-Founder)Rahul Bhansali(CBO, Co-Founder)
Developer of Fc-fusion-based vaccines and boosters for infectious diseases, offering durable safety, broad-spectrum immunity, and room-temperature stability for global access.
Portfolio news
latest coverage across their companiesAkston Biosciences · streetinsider.com · May 4, 2026
Frequently asked questions
- How many investments has Formation Venture Engineering made?
- Formation Venture Engineering has 12 tracked investments.
- What stage does Formation Venture Engineering invest at?
- Formation Venture Engineering invests at the Pre-Seed stage.
- What sectors does Formation Venture Engineering focus on?
- Formation Venture Engineering focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
- Where is Formation Venture Engineering located?
- Formation Venture Engineering is headquartered in Boston.
Media · Podcasts & interviews
featuring the teamFormation Venture Engineering Presentation by Rahul Bhansali, FreeMind Elite
FreeMind Group · Rahul Bhansali
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.